![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
McKesson Corporation | NYSE:MCK | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
5.78 | 0.96% | 605.94 | 606.00 | 598.15 | 601.40 | 219,364 | 16:59:19 |
The Board of Directors of McKesson Corporation (NYSE:MCK) declared on July 21, 2023 a regular dividend of $0.62 per share of common stock, a 15% increase from $0.54 per share in the prior quarter. The dividend will be payable on October 2, 2023, to stockholders of record on September 1, 2023.
“The dividend increase reflects confidence in our strategy and ability to generate sustained strong cash flows,” said Brian Tyler, chief executive officer. “We continue to remain disciplined in our approach to capital deployment and focused on driving sustainable growth while creating value for our shareholders.”
McKesson has increased its dividend for seven consecutive years.
About McKesson Corporation
McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Our Stories.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230721821291/en/
Rachel Rodriguez, 469-260-0556 (Investors) Rachel.Rodriguez@McKesson.com
David Matthews, 214-952-0833 (Media) David.Matthews@McKesson.com
1 Year McKesson Chart |
1 Month McKesson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions